Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States (Including U.S. Territories), July 2017.

Oduyebo T, Polen KD, Walke HT, Reagan-Steiner S, Lathrop E, Rabe IB, Kuhnert-Tallman WL, Martin SW, Walker AT, Gregory CJ, Ades EW, Carroll DS, Rivera M, Perez-Padilla J, Gould C, Nemhauser JB, Ben Beard C, Harcourt JL, Viens L, Johansson M, Ellington SR, Petersen E, Smith LA, Reichard J, Munoz-Jordan J, Beach MJ, Rose DA, Barzilay E, Noonan-Smith M, Jamieson DJ, Zaki SR, Petersen LR, Honein MA, Meaney-Delman D.

MMWR Morb Mortal Wkly Rep. 2017 Jul 28;66(29):781-793. doi: 10.15585/mmwr.mm6629e1.

2.

Augmented Passive Immunotherapy with P4 Peptide Improves Phagocyte Activity in Severe Sepsis.

Morton B, Mitsi E, Pennington SH, Reiné J, Wright AD, Parker R, Welters ID, Blakey JD, Rajam G, Ades EW, Ferreira DM, Wang D, Kadioglu A, Gordon SB.

Shock. 2016 Dec;46(6):635-641.

PMID:
27488089
3.

A Proteomic Characterization of Bordetella pertussis Clinical Isolates Associated with a California State Pertussis Outbreak.

Williamson YM, Moura H, Whitmon J, Woolfitt AR, Schieltz DM, Rees JC, Guo S, Kirkham H, Bouck D, Ades EW, Tondella ML, Carlone GM, Sampson JS, Barr JR.

Int J Proteomics. 2015;2015:536537. doi: 10.1155/2015/536537. Epub 2015 May 24.

4.

Prediction and characterization of helper T-cell epitopes from pneumococcal surface adhesin A.

Singh R, Gupta P, Sharma PK, Ades EW, Hollingshead SK, Singh S, Lillard JW.

Immunology. 2014 Apr;141(4):514-30. doi: 10.1111/imm.12194.

5.

Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations.

Bangert M, Wright AK, Rylance J, Kelly MJ, Wright AD, Carlone GM, Sampson JS, Rajam G, Ades EW, Kadioglu A, Gordon SB.

Antimicrob Agents Chemother. 2013 Sep;57(9):4566-9. doi: 10.1128/AAC.00742-13. Epub 2013 Jul 1.

6.

P4-mediated antibody therapy in an acute model of invasive pneumococcal disease.

Bangert M, Bricio-Moreno L, Gore S, Rajam G, Ades EW, Gordon SB, Kadioglu A.

J Infect Dis. 2012 May 1;205(9):1399-407. doi: 10.1093/infdis/jis223. Epub 2012 Mar 29.

PMID:
22457294
7.

Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.

Nguyen HT, Trujillo AA, Sheu TG, Levine M, Mishin VP, Shaw M, Ades EW, Klimov AI, Fry AM, Gubareva LV.

Antiviral Res. 2012 Mar;93(3):381-6. doi: 10.1016/j.antiviral.2012.01.006. Epub 2012 Feb 7.

PMID:
22330888
8.

A rapid method for capture and identification of immunogenic proteins in Bordetella pertussis enriched membranes fractions: a fast-track strategy applicable to other microorganisms.

West R, Whitmon J, Williamson YM, Moura H, Nelson M, Melnick N, Tondella ML, Schieltz D, Rees J, Woolfitt AR, Barr JR, Ades EW, Carlone GM, Sampson JS.

J Proteomics. 2012 Mar 16;75(6):1966-72. doi: 10.1016/j.jprot.2011.12.034. Epub 2012 Jan 5.

PMID:
22245551
9.

A Novel Innate Immune-Enhancement Strategy Combined with IVIG Rescues Mice from Fatal Staphylococcus aureus Septicemia.

Rajam G, Hammons GM, Carlone GM, Sampson JS, Ades EW.

Int J Microbiol. 2011;2011:725483. doi: 10.1155/2011/725483. Epub 2011 Nov 16.

10.

Use of 2 pneumococcal common protein real-time polymerase chain reaction assays in healthy children colonized with Streptococcus pneumoniae.

Rouphael N, Steyn S, Bangert M, Sampson JS, Adrian P, Madhi SA, Klugman KP, Ades EW.

Diagn Microbiol Infect Dis. 2011 Aug;70(4):452-4. doi: 10.1016/j.diagmicrobio.2010.09.006. Epub 2011 Mar 12.

PMID:
21397430
11.

Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.

Weeks JN, Boyd KL, Rajam G, Ades EW, McCullers JA.

Antimicrob Agents Chemother. 2011 May;55(5):2276-81. doi: 10.1128/AAC.00057-11. Epub 2011 Mar 7.

12.

P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis.

Rajam G, Bangert M, Hammons GM, Melnick N, Carlone GM, Sampson JS, Ades EW.

Clin Vaccine Immunol. 2010 Nov;17(11):1823-4. doi: 10.1128/CVI.00366-10. Epub 2010 Sep 15. No abstract available.

13.

An augmented passive immune therapy to treat fulminant bacterial infections.

Rajam G, Sampson J, Carlone GM, Ades EW.

Recent Pat Antiinfect Drug Discov. 2010 Jun;5(2):157-67. Review.

PMID:
20370679
14.

Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model.

Whaley MJ, Sampson JS, Johnson SE, Rajam G, Stinson-Parks A, Holder P, Mauro E, Romero-Steiner S, Carlone GM, Ades EW.

Vaccine. 2010 Apr 19;28(18):3071-5. doi: 10.1016/j.vaccine.2010.02.086. Epub 2010 Mar 4.

PMID:
20206671
15.

Evaluation of a novel therapeutic approach to treating severe pneumococcal infection using a mouse model.

Melnick N, Rajam G, Carlone GM, Sampson JS, Ades EW.

Clin Vaccine Immunol. 2009 Jun;16(6):806-10. doi: 10.1128/CVI.00120-09. Epub 2009 Apr 22. Erratum in: Clin Vaccine Immunol. 2009 Jul;16(7):1093.

16.

A 28-aa pneumococcal surface adhesin A-derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection.

Rajam G, Skinner J, Melnick N, Martinez J, Carlone GM, Sampson JS, Ades EW.

J Infect Dis. 2009 Apr 15;199(8):1233-8. doi: 10.1086/597425.

PMID:
19265478
17.

Pneumococcal surface adhesin A (PsaA): a review.

Rajam G, Anderton JM, Carlone GM, Sampson JS, Ades EW.

Crit Rev Microbiol. 2008;34(3-4):163-73. doi: 10.1080/10408410802383610. Retraction in: Crit Rev Microbiol. 2009 Feb;35(1):67.

PMID:
18819028
18.

Pneumococcal surface adhesin A (PsaA): a review.

Rajam G, Anderton JM, Carlone GM, Sampson JS, Ades EW.

Crit Rev Microbiol. 2008;34(3-4):131-42. doi: 10.1080/10408410802275352 . Review.

PMID:
18728990
19.

A real-time polymerase chain reaction for the detection of Streptococcus pneumoniae in blood using a mouse model: a potential new "gold standard".

Rouphael NG, Atwell-Melnick N, Longo D, Whaley M, Carlone GM, Sampson JS, Ades EW.

Diagn Microbiol Infect Dis. 2008 Sep;62(1):23-5. doi: 10.1016/j.diagmicrobio.2008.06.002. Epub 2008 Jul 14.

PMID:
18621498
20.

A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization.

Rajam G, Phillips DJ, White E, Anderton J, Hooper CW, Sampson JS, Carlone GM, Ades EW, Romero-Steiner S.

Microb Pathog. 2008 Mar;44(3):186-96. Epub 2007 Oct 5.

PMID:
17997274
21.

Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.

Basset A, Thompson CM, Hollingshead SK, Briles DE, Ades EW, Lipsitch M, Malley R.

Infect Immun. 2007 Nov;75(11):5460-4. Epub 2007 Aug 13.

22.

Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA.

Carvalho Mda G, Tondella ML, McCaustland K, Weidlich L, McGee L, Mayer LW, Steigerwalt A, Whaley M, Facklam RR, Fields B, Carlone G, Ades EW, Dagan R, Sampson JS.

J Clin Microbiol. 2007 Aug;45(8):2460-6. Epub 2007 May 30.

23.

E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae.

Anderton JM, Rajam G, Romero-Steiner S, Summer S, Kowalczyk AP, Carlone GM, Sampson JS, Ades EW.

Microb Pathog. 2007 May-Jun;42(5-6):225-36. Epub 2007 Feb 27.

PMID:
17412553
24.

Entry and intracellular replication of Mycobacterium tuberculosis in cultured human microvascular endothelial cells.

Mehta PK, Karls RK, White EH, Ades EW, Quinn FD.

Microb Pathog. 2006 Aug-Sep;41(2-3):119-24. Epub 2006 Jul 24.

PMID:
16860530
25.

CCL5 modulates pneumococcal immunity and carriage.

Palaniappan R, Singh S, Singh UP, Singh R, Ades EW, Briles DE, Hollingshead SK, Royal W 3rd, Sampson JS, Stiles JK, Taub DD, Lillard JW Jr.

J Immunol. 2006 Feb 15;176(4):2346-56.

26.

Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage.

Palaniappan R, Singh S, Singh UP, Sakthivel SK, Ades EW, Briles DE, Hollingshead SK, Paton JC, Sampson JS, Lillard JW Jr.

Infect Immun. 2005 Feb;73(2):1006-13.

27.

Magnitude of alloresponses to MHC class I/II expressing human cardiac myocytes is limited by their intrinsic ability to process and present antigenic peptides.

Sundstrom JB, Jollow KC, Braud V, Villinger F, McMichael AJ, Lawrencec EC, Ades EW, Ansari AA.

Clin Dev Immunol. 2003 Jun-Dec;10(2-4):213-26.

28.

Analysis of recombinant acylated pneumococcal surface adhesin A of Streptococcus pneumoniae by mass spectrometry.

De BK, Woolfitt AR, Barr JR, Daneshvar MI, Sampson JS, Ades EW, Carlone GM.

Arch Biochem Biophys. 2003 Nov 15;419(2):147-57.

PMID:
14592458
29.

Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.

Briles DE, Hollingshead SK, Paton JC, Ades EW, Novak L, van Ginkel FW, Benjamin WH Jr.

J Infect Dis. 2003 Aug 1;188(3):339-48. Epub 2003 Jul 14.

PMID:
12870114
30.

Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies.

Romero-Steiner S, Pilishvili T, Sampson JS, Johnson SE, Stinson A, Carlone GM, Ades EW.

Clin Diagn Lab Immunol. 2003 Mar;10(2):246-51.

31.

Newly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies.

Marston EL, James AV, Parker JT, Hart JC, Brown TM, Messmer TO, Jue DL, Black CM, Carlone GM, Ades EW, Sampson J.

Clin Diagn Lab Immunol. 2002 Mar;9(2):446-52.

32.

Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin a.

Johnson SE, Dykes JK, Jue DL, Sampson JS, Carlone GM, Ades EW.

J Infect Dis. 2002 Feb 15;185(4):489-96. Epub 2002 Jan 31.

PMID:
11865401
33.

Pneumococcal surface adhesin A antibody concentration in serum and nasopharyngeal carriage of Streptococcus pneumoniae in young African infants.

Obaro SK, Adegbola RA, Tharpe JA, Ades EW, McAdam KP, Carlone G, Sampson JS.

Vaccine. 2000 Oct 15;19(4-5):411-2. No abstract available.

PMID:
11027802
34.

Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model.

Lipsitch M, Dykes JK, Johnson SE, Ades EW, King J, Briles DE, Carlone GM.

Vaccine. 2000 Jun 15;18(25):2895-901. Erratum in: Vaccine 2000 Oct 15;19(4-5):598.

PMID:
10812233
35.

Selection of an immunogenic and protective epitope of the PsaA protein of Streptococcus pneumoniae using a phage display library.

Srivastava N, Zeiler JL, Smithson SL, Carlone GM, Ades EW, Sampson JS, Johnson SE, Kieber-Emmons T, Westerink MA.

Hybridoma. 2000 Feb;19(1):23-31.

PMID:
10768838
36.

Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli.

De BK, Sampson JS, Ades EW, Huebner RC, Jue DL, Johnson SE, Espina M, Stinson AR, Briles DE, Carlone GM.

Vaccine. 2000 Mar 6;18(17):1811-21.

PMID:
10699329
37.

Baculovirus expression, purification and evaluation of recombinant pneumococcal surface adhesin A of Streptococcus pneumoniae.

De BK, Sampson JS, Ades EW, Johnson SE, Stinson AR, Crook J, Tharpe JA, Huebner RC, Carlone GM.

Pathobiology. 1999 May-Jun;67(3):115-22.

PMID:
10394131
38.

The anticancer drug edelfosine is a potent inhibitor of neovascularization in vivo.

Vogler WR, Liu J, Volpert O, Ades EW, Bouck N.

Cancer Invest. 1998;16(8):549-53.

PMID:
9844614
39.

Comparison of a pneumococcal common protein (PsaA) antibody ELISA and a PsaA immune complex ELISA for detection of pneumococcal serum antibody.

Tharpe JA, Russell H, Leinonen M, Plikaytis BD, Breiman RF, Carlone GM, Ades EW, Sampson JS.

Pathobiology. 1998;66(2):77-83.

PMID:
9645631
40.

Culture and characterization of sinusoidal endothelial cells isolated from human liver.

Daneker GW, Lund SA, Caughman SW, Swerlick RA, Fischer AH, Staley CA, Ades EW.

In Vitro Cell Dev Biol Anim. 1998 May;34(5):370-7.

PMID:
9639099
41.

Immunoreactivity of five monoclonal antibodies against the 37-kilodalton common cell wall protein (PsaA) of Streptococcus pneumoniae.

Crook J, Tharpe JA, Johnson SE, Williams DB, Stinson AR, Facklam RR, Ades EW, Carlone GM, Sampson JS.

Clin Diagn Lab Immunol. 1998 Mar;5(2):205-10.

42.

BMEC-1: a human bone marrow microvascular endothelial cell line with primary cell characteristics.

Candal FJ, Rafii S, Parker JT, Ades EW, Ferris B, Nachman RL, Kellar KL.

Microvasc Res. 1996 Nov;52(3):221-34.

PMID:
8954864
43.

Plasmodium falciparum: involvement of additional receptors in the cytoadherence of infected erythrocytes to microvascular endothelial cells.

Xiao L, Yang C, Dorovini-Zis K, Tandon NN, Ades EW, Lal AA, Udhayakumar V.

Exp Parasitol. 1996 Oct;84(1):42-55.

PMID:
8925881
44.
45.

Endotoxin removal using 6,000 molecular weight cut-off polyacrylonitrile (PAN) and polysulfone (PS) hollow fiber ultrafilters.

Evans-Strickfaden TT, Oshima KH, Highsmith AK, Ades EW.

PDA J Pharm Sci Technol. 1996 May-Jun;50(3):154-7.

PMID:
8696778
46.
47.

Seeding of intracoronary stents with immortalized human microvascular endothelial cells.

Scott NA, Candal FJ, Robinson KA, Ades EW.

Am Heart J. 1995 May;129(5):860-6.

PMID:
7732973
48.

The removal of phages T1 and PP7, and poliovirus from fluids with hollow-fiber ultrafilters with molecular weight cut-offs of 50,000, 13,000, and 6000.

Oshima KH, Evans-Strickfaden TT, Highsmith AK, Ades EW.

Can J Microbiol. 1995 Apr-May;41(4-5):316-22.

PMID:
8590412
49.

Seeding of vascular grafts with an immortalized human dermal microvascular endothelial cell line.

Robinson KA, Candal FJ, Scott NA, Ades EW.

Angiology. 1995 Feb;46(2):107-13.

PMID:
7702194
50.

Supplemental Content

Support Center